Publication | Open Access

Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

Pkc412 InhibitorImatinib-resistant MutantsGastrointestinal OncologyMedicinePathologyGastrointestinal Stromal TumorsCancer BiologyTumor SuppressorOncologyCell BiologyTumor BiologyCancer Growth